15th June 2012 Ismini Chatzitheofilou in Health Economics, Pharmacoeconomics, Ageing

• 

  Imaging Agent Flutemetamol Presented At Neurology Meeting

  Editor's ChoiceMain Category: Radiology / Nuclear Medicine Also Included In:MRI / PET / Ultrasound Article Date: 03 May 2012 - 9:00 PDT Results from 4 pooled brain biopsy studies, as well as results from a brain autopsy study of the investigational PET amyloid imaging agent, [18F]flutemetamol, were presented as part of the Emerging Science Program at the American Academy of Neurology's 64th Annual Meeting in New Orleans in April, 2012.